Stockreport

Beam Therapeutics Inc (BEAM) Q3 2024 Earnings Call Highlights: Promising BEACON Trial Results ... [Yahoo! Finance]

Beam Therapeutics Inc.  (BEAM) 
PDF BEAM-101 Efficacy: Achieved greater than 60% fetal hemoglobin (HbF) induction and reduced sickle hemoglobin (HbS) to less than 40% in patients. Neutrophil Engraftment [Read more]